CORONA, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) --
Dear Shareholders: I’m pleased to tell you that our application to FINRA has been approved and they have formally changed both our business name and stock symbol. We are now formally MedTainer Inc. and our new call letters are MDTR. (MDTR-OTCMARKETS) From the point that we determined to completely own all of the MedTainer™ intellectual property to this announcement today and the continuation of actions taken by the company over the course of the last two years I can confirm that our market share is steadily increasing, and our value has sharply risen.
All the effort that we’ve put into our Canadian operations have begun to pay off. We continue to see new orders from all the major LPs and just recently received a large order from a new, emerging LP that shows great promise. This is only one of many new opportunities that are emerging for us in Canada. Aurora Cannabis’ (ACBFF-U.S.:OTC) order increased last week and we were featured in a story on EQUITIES.COM which detailed many of our recent success. (https://www.equities.com/news/why-licensed-producers-like-aurora-are-choosing-meditainer) Our production tables are filled with orders and our printing operations are in full gear. We are meeting every challenge and exceeding even our most ardent supporters’ expectations.
Obviously, we are bullish on the future. As our position in the California market continues to grow we fully expect to fulfill the needs of this rapidly-expanding market. To that end we are continually acquiring new data as state licenses are granted. Our sales department is very active in calling and selling new clients. These include dispensaries, smoke shops, retail sellers, wholesalers and various cannabis market opportunists around the world. This single aspect of our business has grown by more than 150% in the last three years. Our active customer downline has grown by more than 225% since 2015.
As I’ve said before, I share your impatience with certain aspects of our market and how it has evolved. However, it is my firm belief that we are seeing the end of that period. Our marketplace is only now just beginning to scratch the surface of its potential. I am very confident that our company, MedTainer Inc., will continue to lead in compliant packaging. I can also foreshadow new products being manufactured and shortly made available to our sales partners. As we near the end of 2018 and begin to narrow our focus on the year ahead I am pleased to tell you that our company has never been stronger or in a better position to take advantage of the opportunities that will present themselves to us as we move forward. Thank you, as always, for your continued support and confidence.
Sincerely, Curt
For investor or sales information please visit MedTainer Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
MedTainer Inc. currently trades on the OTC under the call letters ACOL. The company’s websites are www.Medtainerinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for MedTainer products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@Medtainerinc.com or call (844) 226-5649. Ask for Jack Rein, National Services Director. MedTainer can also be accessed through Twitter and Instagram at @Medtainerinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.